The Latest Breaking News from Disease

A study has found that healthy habits such as nicotine avoidance and healthy eating in young adult life can slash your risk of cardiovascular disease

More than three-quarters of U.S. counties and jurisdictions are experiencing declines in childhood vaccination rates, a trend that began in 2019, according to a September 2025 NBC News–Stanford University investigation. The report also found a “large swath” of the U.S. no longer has the “basic, ground-level immunity” needed to stop…

The new combination of drugs could increase life expectancy in what researchers called a ‘striking’ finding

Former England captain Moody shared news of his diagnosis on Monday morning.

Reports of lung disease, skin conditions and even cancer are rising in Panipat, which recycles 1 million tonnes of textile waste a year

Whether you love them or avoid them, genetically modified fruits—better known as GMOs—have become impossible to ignore. From apples that don’t brown to papayas that resist disease, GMO fruit has quietly made its way onto grocery store shelves around the world. Yet confusion remains high, and misinformation spreads faster than…

Every day, your immune system performs a delicate balancing act, defending you from thousands of pathogens that cause disease while sparing your body’s own healthy cells. This careful equilibrium is so seamless that most people don’t think about it until something goes wrong.

Some studies find an increased MND risk for rugby players, others show the risk is equally high for others. The only way forward is more research

The Centers for Disease Control and Prevention has adopted recommendations by a new group of vaccine advisers, and has stopped recommending COVID-19 shots for anyone

Former World Cup winner, 47, tells the BBC he has been diagnosed with motor neurone disease

Algen Biotechnologies, a privately held biotech company specializing in advanced CRISPR gene modulation and AI-driven drug discovery, has announced a multi-target partnership with AstraZeneca Plc (NASDAQ:AZN) to accelerate the discovery of novel therapeutic targets in immunology.